![Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2021204112/asset/images/medium/radiol.2021204112.va.gif)
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
![Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/693684/693684_Thumb_400.jpg)
Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
![performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram](https://www.researchgate.net/publication/10978140/figure/tbl2/AS:601775400820743@1520485844541/performance-of-PSA-density-with-respect-to-multiple-cutoff-levels-Note-the-unacceptable.png)
performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram
![MP56-09 A RISK CALCULATOR INCORPORATING MRI-GUIDED BIOPSY DATA TO PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER | Journal of Urology MP56-09 A RISK CALCULATOR INCORPORATING MRI-GUIDED BIOPSY DATA TO PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER | Journal of Urology](https://www.auajournals.org/cms/asset/c14cc58a-dba4-426f-9e72-f09b0e565ced/ju.0000000000000925.09t1.gif)
MP56-09 A RISK CALCULATOR INCORPORATING MRI-GUIDED BIOPSY DATA TO PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER | Journal of Urology
![Frontiers | New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3 Frontiers | New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3](https://www.frontiersin.org/files/Articles/908956/fonc-12-908956-HTML/image_m/fonc-12-908956-g001.jpg)
Frontiers | New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
![Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy](https://www.mdpi.com/cancers/cancers-14-02374/article_deploy/html/images/cancers-14-02374-g002b.png)
Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
![SciELO - Brasil - Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and SciELO - Brasil - Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and](https://minio.scielo.br/documentstore/1677-6119/5GWVS9m8y55TZvZ89YVmVbz/e3f287786901ff1f9230b1df00909c7c5795c03c.gif)
SciELO - Brasil - Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and
![Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/ab17d97b-9319-4a00-9a54-1261444c76dc/gr1_lrg.jpg)